title: Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand.
abstract: Platelet markers [soluble CD40 ligand (sCD40L) and soluble p selectin (sPselectin)] are associated with platelet activation and cardiovascular events. We sought to investigate the reproducibility of these markers over time and the effect of low-dose aspirin on sCD40L and sPselectin in plasma and serum. Following an overnight fast, 40 healthy volunteers had weekly phlebotomy and were administered aspirin 81 mg/day between weeks 3 and 4. Reproducibility over time was assessed by coefficient of variation (CV) and inter-class correlation coefficient. Correlation between markers was assessed using Pearson r statistic. Difference between levels pre- and post-aspirin was measured with Wilcoxon signed-rank test. Data are presented as median (interquartile range). sCD40L and sPselectin measurements were reproducible over time in plasma and serum (CV < 10 %). Measurement of sCD40L and sPselectin in plasma correlated with levels in serum before aspirin and after aspirin. There was no significant correlation between sCD40L and sPselectin. After 1-week of aspirin 81 mg/day, there was a reduction in sCD40L and sPselectin in serum and plasma, respectively. Soluble CD40L and sPselectin are independent markers that are reproducible over time in both plasma and sera and are reduced by 1-week of low-dose aspirin.
authors: Division of Cardiology, Department of Medicine, New York University School of Medicine, 530 First Avenue, Skirball 9R, New York, NY, 10016, USA.
authors: Vanessa
authors: V
authors: Valdes
authors: Michael A
authors: MA
authors: Nardi
authors: Lindsay
authors: L
authors: Elbaum
authors: Jeffrey S
authors: JS
authors: Berger
mesh_terms: D000328:Adult; D001241:Aspirin / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D023201:CD40 Ligand / Q000008:administration & dosage* / Q000097:blood*; D006801:Humans; D008875:Middle Aged; D019007:P-Selectin / Q000037:antagonists & inhibitors* / Q000097:blood*; D015203:Reproducibility of Results; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D015415:Biomarkers; D019007:P-Selectin; C546937:SELP protein, human; D023201:CD40 Ligand; D001241:Aspirin
references: Am J Cardiol. 2005 Nov 15;96(10):1365-9
references: 16275179
references: Blood. 2003 Apr 1;101(7):2661-6
references: 12480714
references: Circulation. 2001 Jan 30;103(4):491-5
references: 11157711
references: Thromb Res. 2004;114(2):143-8
references: 15306157
references: Clin Sci (Lond). 2006 Nov;111(5):341-7
references: 16856875
references: Atherosclerosis. 1997 Feb 10;128(2):135-8
references: 9050769
references: J Thromb Thrombolysis. 2011 Aug;32(2):201-8
references: 21562837
references: J Am Coll Cardiol. 2009 Aug 18;54(8):669-77
references: 19679244
references: J Thromb Haemost. 2004 Nov;2(11):2067-9
references: 15550055
references: Clin Biochem. 2010 May;43(7-8):666-70
references: 20060822
references: Clin Chim Acta. 2009 Jan;399(1-2):88-91
references: 18835553
references: Haemostasis. 1997 May-Jun;27(3):119-24
references: 9306128
references: Thromb Res. 2012 Jan;129(1):80-5
references: 21737126
references: Circ Res. 2003 May 16;92(9):944-6
references: 12750303
references: Circulation. 2001 Nov 6;104(19):2266-8
references: 11696462
references: J Thromb Haemost. 2010 Jan;8(1):148-56
references: 19691485
references: Platelets. 2014;25(3):188-92
references: 23786366
references: Intern Emerg Med. 2007 Dec;2(4):256-68
references: 18043876
references: Arch Immunol Ther Exp (Warsz). 2006 Mar-Apr;54(2):75-84
references: 16648968